Genetic Signatures Ltd. Statistics
Want to see AU:GSS full AI Analyst Report?
Genetic Signatures Ltd. (GSS) Stock Statistics & Valuation Metrics
Total Valuation
Genetic Signatures Ltd. has a market cap or net worth of AUD 17.49M. The enterprise value is -AUD 6.57M.
- Market Cap
- AUD 17.49M
- Enterprise Value
- -AUD 6.57M
Share Statistics
Genetic Signatures Ltd. has 227,138,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 227,138,820
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Genetic Signatures Ltd.’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -37.25%.
- Return on Equity (ROE)
- -0.39
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -37.25%
- Return on Capital Employed (ROCE)
- -0.50
- Revenue Per Employee
- 123.53K
- Profits Per Employee
- -119.71K
- Employee Count
- 117
- Asset Turnover
- 0.38
- Inventory Turnover
- 4.38
Valuation Ratios
The current PE Ratio of Genetic Signatures Ltd. is -1.17. Genetic Signatures Ltd.’s PEG ratio is -0.12.
- PE Ratio
- -1.17
- PS Ratio
- 1.00
- PB Ratio
- 0.46
- Price to FCF
- -1.64
- Price to Operating Cash Flow
- -2.10
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, Genetic Signatures Ltd. had revenue of 14.45M and earned -14.01M in profits. Earnings per share was -0.06.
- Revenue
- 14.45M
- Gross Profit
- -12.72M
- Operating Income
- -17.74M
- Pretax Income
- -18.50M
- Net Income
- -14.01M
- EBITDA
- -15.68M
- Earnings Per Share (EPS)
- -0.06
Cash Flow
In the last 12 months, operating cash flow was -7.77M and capital expenditures -1.05M, giving a free cash flow of -8.82M billion.
- Operating Cash Flow
- -7.77M
- Free Cash Flow
- -8.82M
- Free Cash Flow per Share
- -0.04
Dividends & Yields
Genetic Signatures Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -61.06%
- Earnings Yield
- -85.64%
Stock Price Statistics
- Beta
- 0.47
- 52-Week Price Change
- -78.51%
- 50-Day Moving Average
- 0.08
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 38.74
- Average Volume (3m)
- 483.76K
Important Dates
Genetic Signatures Ltd. upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 24, 2026
- Next Earnings Date
- Feb 16, 2027
- Ex-Dividend Date
- ―
Financial Position
Genetic Signatures Ltd. as a current ratio of 13.10, with Debt / Equity ratio of 0.87%
- Current Ratio
- 13.10
- Quick Ratio
- 10.80
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.56
- Interest Coverage Ratio
- -385.72
Taxes
In the past 12 months, Genetic Signatures Ltd. has paid -4.49M in taxes.
- Income Tax
- -4.49M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Genetic Signatures Ltd. EV to EBITDA ratio is -0.36, with an EV/FCF ratio of -0.64.
- EV to Sales
- 0.39
- EV to EBITDA
- -0.36
- EV to Free Cash Flow
- -0.64
- EV to Operating Cash Flow
- -0.73
Balance Sheet
Genetic Signatures Ltd. has AUD 22.09M in cash and marketable securities with AUD 310.00K in debt, giving a net cash position of AUD 21.79M billion.
- Cash & Marketable Securities
- AUD 22.09M
- Total Debt
- AUD 310.00K
- Net Cash
- AUD 21.79M
- Net Cash Per Share
- AUD 0.10
- Tangible Book Value Per Share
- AUD 0.16
Margins
Gross margin is -88.02%, with operating margin of -122.76%, and net profit margin of -96.91%.
- Gross Margin
- -88.02%
- Operating Margin
- -122.76%
- Pretax Margin
- -127.98%
- Net Profit Margin
- -96.91%
- EBITDA Margin
- -108.49%
- EBIT Margin
- -122.76%
Analyst Forecast
The average price target for Genetic Signatures Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -9.10%
- EPS Growth Forecast
- 31.75%
Scores
- Smart Score
- 4
- AI Score
- 47
